Physician profile
Jaclyn Hill
NPI 1477758050
$69,535.54
in general payments reported to CMS, 2019-2025
8 companies · $26K in 2025
The $26K reported for 2025 was more than what 96% of Pediatric Orthopaedic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,510 · 2020: $10K · 2021: $12K · 2022: $4,512 · 2023: $9,157 · 2024: $2,213 · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $32K · Travel and Lodging: $4,594 · Food and Beverage: $687.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $32,000.00 |
| Travel and Lodging | $4,593.94 |
| Food and Beverage | $687.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $42,794.27 | 2019-2025 | Hoffmann, Variax, Gamma |
| Orthopediatrics Corp. | $21,966.74 | 2019-2025 | |
| Nuvasive Specialized Orthopedics, INC. | $4,252.53 | 2019-2021 | |
| Nuvasive, INC. | $173.79 | 2019 | |
| Evolution Surgical, INC | $147.41 | 2023 | |
| Bone Support INC. | $96.62 | 2019 | |
| Depuy Synthes Sales INC. | $89.15 | 2022 | |
| Globus Medical, INC. | $15.03 | 2023 | Tibial Nail |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaclyn Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.